The DOI matches its Crossref record; 119 of the 128 references it cites were found in a registry or an index; 28 of the 59 sources its claims cite were checked for support.
A Female-Specific Treatment Group for ADHD—Description of the Programme and Qualitative Analysis of First Experiences
Open accessAbstract
Background: The diagnostics and treatment of attention-deficit/hyperactivity disorder (ADHD) in women remain insufficient. Fluctuations of reproductive hormones during the premenstrual period, postpartum period, and (peri)menopause are neglected, even though they impact ADHD symptoms and associated mood disorders. Therefore, we created a female-specific treatment group for women with ADHD and premenstrual worsening of ADHD and/or mood symptoms. Methods: We describe the group programme and underlying rationale, offering a qualitative analysis of the participants’ evaluation. Results: The seven bi-weekly sessions foreground the menstrual cycle and address several ADHD-specific topics in relation to this cyclical pattern. Concurrently, women track their menstrual cycle and (fluctuating) ADHD and mood symptoms with an adjusted premenstrual calendar. In total, 18 women (25–47 years) participated in three consecutive groups. We analysed the evaluation of the last group. Participants experienced the group as a safe and welcoming space. Recognition was valued by all. The topics discussed were deemed valuable, and the structure suited them well. Completing the premenstrual calendar augmented the awareness and recognition of individual cyclical symptoms. A lifespan approach increased self-understanding. Participants took their menstrual cycle more seriously, prioritising self-acceptance and self-care. Conclusions: Exploring a cyclical approach in a group setting seems to be a positive addition to treatment for female ADHD. © 2024 by the authors.
Overview
CoChat Summary
TL;DR
The paper describes a seven-session, female-specific ADHD group that foregrounds the menstrual cycle and reports participants’ first experiences with it. In the final group’s qualitative evaluation, women described the program as a safe, welcoming, and well-fitting space that increased recognition, self-understanding, and self-care.
Key findings
- The program consisted of seven bi-weekly, two-hour sessions; women tracked menstrual cycle, ADHD, mood, and somatic symptoms with an adjusted “PMS calendar” throughout the group.
- Across three consecutive groups, 18 women aged 25–47 years participated; the paper qualitatively analyzed the evaluation of the last group only.
- In the final evaluation, the team identified six key themes: safety-sharing-welcome, recognition, good fit, eyeopener, take(n) seriously, and empathy, with two overarching themes: understanding and connection.
- Participants reported that the program made them more aware of cyclical symptoms, helped them take their menstrual cycle more seriously, and supported self-acceptance and self-care; the paper also notes that the last group’s evaluation lasted 36 minutes and included 5 of the 6 participants in person, with the sixth contributing by email.
Methods
- The authors described the development and content of a female-specific treatment group offered as part of routine outpatient adult ADHD care at PsyQ, The Hague, the Netherlands, alongside a qualitative thematic analysis of the final group evaluation.
- Participants were women with ADHD and subjective menstrual cycle-related worsening of ADHD and/or mood symptoms; the paper states that all women had received psychiatric assessment, with ADHD diagnosed or confirmed using the DIVA-5 interview.
- Data collection used a semi-structured collective interview in Dutch; audio was transcribed verbatim, pseudonymized, and analyzed inductively by multiple researchers until final consensus on themes was reached.
Limitations
- The paper states that it analyzed the evaluation of only one group (the last), not the first two groups.
- The final evaluation was conducted by the same clinicians who designed and led the group, which the authors note might have hindered negative feedback; they partly addressed this with independent researcher triangulation.
- The authors state they had completed only three groups so far, and they did not measure the effect of the group; this is evident in the text and means no outcome effect estimates are reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 1 Overview of the female-specific treatment group for ADHD. The programme consists of 7 sessions of two hours that are given every other week, and all have their own focus. The PMS calendar functions as a connecting thread (Appendix A). All sessions have a similar structure. Every session starts with a 5 min body scan meditation. Homework and the PMS calendar are discussed. After a break, the content section consists of a combination of theory and (individual) experiences. Every session ends with the homework assignment for the next session. During the body scan, under verbal instruction from a therapist, participants are encouraged to move attention sequentially via the body, paying attention to present moment sensory experience in each body area without trying to change anything [48]. The PMS calendar was devised and adjusted in collaboration with participants of previous groups. For the duration of the group programme (about 16 weeks), participants use it to track their menstrual cycle, ADHD, mood, and somatic symptoms.](https://figures.cochat.ai/paper-figures/ec82cc8795424ec9949065516872835d/a-female-specific-treatment-group-for-adhddescription-of-the-programme-and-figure-1.jpg)

Verification
Claims the paper makes
17 Valid · 0 Not valid · 6 Not checked · 106 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“For women [18], and women with ADHD especially [19,20], the menstrual cycle probably influences these symptoms.”
§ A Female-Specific Treatment Group for ADHD—Description of the Programme and Qualitative Analysis of First Experiences > 1. Introduction
What the sources say
- Supportedcites [18] Handy, 2022, Psychiatric Symptoms Across the Menstrual Cycle in Adult Women: A Comprehensive Review, Harv. Rev. Psychiatry source
The Abstract (page not provided) reports menstrual-cycle-dependent fluctuations in psychiatric symptoms among adult women, including depression and mania. The citing sentence attaches this review to the claim about women generally; it attaches separate citations [19,20] to the stronger claim about women with ADHD. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [19] Eng, 2023, Attention-deficit/hyperactivity disorder and the menstrual cycle: Theory and evidence, Horm. Behav. source
- Supportedcites [20] Dorani, 2021, Prevalence of hormone-related mood disorder symptoms in women with ADHD, J. Psychiatr. Res. source
The Discussion says hormonal changes across the menstrual cycle are suggested to affect ADHD symptom severity and that hormonal fluctuations may have more impact on women with ADHD. The Introduction also reports clinical experience of more severe mood changes during hormonal changes in women with ADHD. These passages support the citing sentence’s tentative wording; page numbers are not available in our copy. (LLM, conf=0.89)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“We decided on a group programme because of the importance of social difficulties for women with ADHD [10,17].”
§ A Female-Specific Treatment Group for ADHD—Description of the Programme and Qualitative Analysis of First Experiences > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [10] Faheem, 2022, Gender-based differences in prevalence and effects of ADHD in adults: A systematic review, Asian J. Psychiatry source
- Supportedcites [17] Attoe, 2023, Miss. Diagnosis: A Systematic Review of ADHD in Adult Women, J. Atten. Disord. source
The Results & Discussion section identifies difficulties in social relations and peer relationships as significant findings for women with ADHD. This supports the cited rationale that social difficulties are important; the citation need not establish that a group programme is effective. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, we recently described the benefits of increasing psychostimulant dosage in the premenstrual week for nine women with ADHD and premenstrual worsening of ADHD and/or mood symptoms [42].”
§ A Female-Specific Treatment Group for ADHD—Description of the Programme and Qualitative Analysis of First Experiences > 1. Introduction
What the sources say
- Supportedcites [42] Wynchank, 2023, Female-specific pharmacotherapy in ADHD: Premenstrual adjustment of psychostimulant dosage, Front. Psychiatry source
The Abstract Results report that all nine women experienced improved ADHD and mood symptoms after premenstrual dose elevation. The Discussion identifies them as women with ADHD who reported premenstrual worsening, matching the citing sentence’s description of this small case study. (LLM, conf=0.94)
plainstates a causen = 9- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Our group previously showed that women with ADHD have a higher prevalence of mood disorders than what is seen in the general population during three major periods of reproductive hormone fluctuation: the premenstrual period, postpartum, and (peri)menopause [20].”
§ A Female-Specific Treatment Group for ADHD—Description of the Programme and Qualitative Analysis of First Experiences > 1. Introduction
What the sources say
- Partly supportedcites [20] Dorani, 2021, Prevalence of hormone-related mood disorder symptoms in women with ADHD, J. Psychiatr. Res. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports higher self-reported indications of PMDD and postpartum depression in the ADHD sample than published general-population rates, and more climacteric symptoms among peri- and postmenopausal participants. But the Design section says the PMDD and postpartum comparisons were not statistically tested because of selection bias, and the Discussion describes the overall finding as a possible elevation in symptoms. The claim overstates these cautious symptom-based findings as an established higher prevalence of mood disorders across all three periods. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Compared to the general population, women with ADHD are at increased risk of depression and depressive symptoms during periods of ovarian hormone fluctuations [20,41,89,90].”
§ A Female-Specific Treatment Group for ADHD—Description of the Programme and Qualitative Analysis of First Experiences > 4. Discussion We describe here a group programme specifically designed for women with ADHD and self-reported premenstrual worsening of ADHD and/or mood symptoms that was offered as an adjunct to the outpatient adult ADHD treatment at PsyQ, The Hague, the Netherlands. This is the first time, to our knowledge, that a therapeutic intervention specifically tailored to the menstrual cycle in ADHD is described. Also, we present a thematic qualitative analysis of the final evaluation of our last group, which reflects the participants’ experience of the group programme. Participants considered the topics valuable and the programme structure well tailored to them. The group was experienced as a safe and welcoming space. Recognition in each other as well as in the provided theory and PMS calendar (Appendix A) was insightful and valued by all. Discussing ADHD throughout the female lifespan increased self-understanding and resulted in a shift in self-regard. At the final evaluation, participants took their menstrual cycle more seriously, prioritising self-acceptance and self-care in the luteal phase of their cycle. This was described as an ongoing process. There was ambivalence about the time investment required, and some participants found the emphasis on the menstrual cycle a bit too strong. Others valued this approach. The key themes that were identified via thematic qualitative analysis of the final evaluation were eyeopener, good fit, recognition, take(n) seriously, empathy, and safety/sharing/welcome (Figure 2). Additionally, we identified two overarching themes: understanding and connection (Figure 2). We developed this female-specific treatment option in response to the dire need expressed by many [1,17,19,23,24,25,26,28,41,55,85], including patients. The programme is explicitly a product of combining and integrating our clinical experience with the available scientific evidence. Importantly, we do not claim that our programme design is optimal. We hope to boost the parallel and collaborative development of female-specific therapeutic options for ADHD and emerging sex-specific evidence. The group, consisting of seven sessions, foregrounds the menstrual cycle and addresses several ADHD-related topics in relation to this fluctuating pattern: childhood, emotionality, impulsivity, boundaries and safety, and triggers (Figure 1). During the group, participants track their menstrual cycle and possibly related symptoms with a PMS calendar (Appendix A). We advise that this programme be considered in addition to pharmacological and non-pharmacological treatment as usual and not be used as a substitute. > 4.1. Merging Practice and Research
What the sources say
- Partly supportedcites [20] Dorani, 2021, Prevalence of hormone-related mood disorder symptoms in women with ADHD, J. Psychiatr. Res. sourceExperimental — accuracy not yet measured
The Discussion reports higher self-reported rates of PMDD, postpartum depression, and climacteric symptoms in women with ADHD than rates reported for the general population. It calls the findings preliminary and says the comparisons require caution because the study lacked a matched control group. The claim states an increased risk as established, which is stronger than the paper's conclusion of a possible elevation. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Quinn, 2005, Treating adolescent girls and women with ADHD: Gender-specific issues, J. Clin. Psychol. source
- Not checked — no full text of the sourcecites [89] Deecher, 2008, From menarche to menopause: Exploring the underlying biology of depression in women experiencing hormonal changes, Psychoneuroendocrinology source
- Partly supportedcites [90] Epperson, 2012, Premenstrual dysphoric disorder: Evidence for a new category for DSM-5, Am. J. Psychiatry sourceExperimental — accuracy not yet measured
The Concurrent Validators section reports that women with premenstrual dysphoric disorder, unlike healthy comparison subjects, experienced a return of negative affect when estradiol or progesterone was reintroduced. This supports a link between ovarian hormones and mood symptoms in that disorder, but the paper does not establish that women with ADHD have increased depression risk relative to the general population. (LLM, conf=0.83)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
60 more claims · 4 with their cited sources checked
Create a free account to see all 129 claims and to verify the 2 references still open.
- Probably not a substantial claim. 33
- It may state two separate claims as one. 43
- The quote only partly states this claim. 2
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
(1998) · PubMed · Cited by 10,216
Kabat-Zinn, J. (1982) · General Hospital Psychiatry · doi:10.1016/0163-8343(82)90026-3 · Cited by 4,255 · cited 1×
“The body scan developed as a part of mindfulness-based stress reduction [108] has been shown to be effective in stress reduction, increased self-compassion, decreased rumination, and medical symptom relief [48].”
BackgroundFaraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545 · cited 2×
“While psychostimulants are the mainstay of ADHD treatment, multi-modal treatment has been shown to improve treatment effects [21,22].”
BackgroundSelf-citationThe prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
Halbreich, U., Borenstein, J., Pearlstein, T., & Kahn, L. S. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00098-2 · Cited by 740
Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1463-3 · Cited by 732 · cited 1×
“ADHD has high comorbidity [44,45].”
Barth, C., Villringer, A., & Sacher, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00037 · Cited by 711
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.11.001 · Cited by 686 · cited 1×
“In accordance with international guidelines [43], all patients receive a combination of pharmacological and non-pharmacological treatment, which includes psychoeducation and skills training to help them manage their symptoms.”
BackgroundSelf-citationReaction time variability in ADHD: A meta-analytic review of 319 studies
Kofler, M. J., Rapport, M. D., Sarver, D. E., Raiker, J. S., Orban, S. A., Friedman, L. M., & Kolomeyer, E. G. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2013.06.001 · Cited by 648
Young, S., Adamo, N., Ásgeirsdóttir, B. B., Branney, P., Beckett, M., Colley, W., Cubbin, S., Deeley, Q., Farrag, E., Gudjonsson, G., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02707-9 · Cited by 610
Cited by
Amiri, D., Briziarelli, L., & Tempesta, E. (2025) · Middle East Current Psychiatry · doi:10.1186/s43045-025-00508-y · Cited by 11
Findeis, H., & Strauß, M. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111261 · Cited by 11
Wynchank, D., Sutrisno, R. M. G. T. M. F., van Andel, E., & Kooij, J. J. S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm15010121 · Cited by 10
“A female-specific treatment group that addressed pre-menstrual worsening of ADHD and mood symptoms was evaluated qualitatively and found to be valuable: women reported feeling recognised, validated, and better able to prioritise self-acceptance and self-care [80].”
Self-citationIntegrative literature review – the impact of ADHD across women’s lifespan
Krebs, K., & Donnellan-Fernandez, R. E. (2025) · BMC Women s Health · doi:10.1186/s12905-025-04123-1 · Cited by 11
“Two Dutch studies focused on female-specific ADHD treatments and the impacts of hormonal fluctuations across the menstrual cycle [27, 28].”
InfluentialHormonal effects on externalizing problems in females across the lifespan
Martel, M. M., Eng, A. G., Nirjar, U., Petersen, M. K., Ramirez, M. P., Litteral, C. A., & Robinson, L. E. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101206 · Cited by 4
Metadata
- Authors
- de Jong, M., Wynchank, D. S. M. R., Michielsen, M., Beekman, A. T. F., & Kooij, J. J. S.
- Affiliations
- Expertise Centre Adult ADHD, PsyQ, 2593 HR The Hague, The Netherlands
- PsyQ (NL)
- GGZ inGeest (NL)
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2024-04-04
- Volume
- 13
- Issue
- 7
- Pages
- 2106
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC11012758
- OpenAlex
- W4393949141
- Cited by
- 11
- References
- 128
- Citations by year
- 2026: 5 · 2025: 6
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- attention deficit hyperactivity disorder, menstrual cycle, group therapy, reproductive hormones, mood disorders, self-care, self-understanding, women's mental health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Female-Specific Treatment Group for ADHD—Description of the Programme and Qualitative Analysis of First Experiences. https://app.cochat.ai/papers/10.3390/jcm13072106
- The paper
- de Jong, M., Wynchank, D. S. M. R., Michielsen, M., Beekman, A. T. F., & Kooij, J. J. S. (2024). A Female-Specific Treatment Group for ADHD—Description of the Programme and Qualitative Analysis of First Experiences. Journal of Clinical Medicine. https://doi.org/10.3390/jcm13072106
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.